# An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

Study · id `cardio:ct-nct06032208` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06032208](<https://clinicaltrials.gov/study/NCT06032208>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06032208

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06032208. Allocation not applicable; no masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06032208, source copy `cardio:ctgov-nct06032208-2026-05-04`, retrieved 2026-10-26)
- Started: 2024-03-01 (actual) (ClinicalTrials.gov record NCT06032208, source copy `cardio:ctgov-nct06032208-2026-05-04`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06032208, source copy `cardio:ctgov-nct06032208-2026-05-04`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06032208, source copy `cardio:ctgov-nct06032208-2026-05-04`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT06032208, source copy `cardio:ctgov-nct06032208-2026-05-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06032208-2026-05-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
- Condition: End Stage Renal Disease
- Intervention (Device): Theranova Dialyzer
- Lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Lead sponsor class: OTHER
- Collaborator: Baxter Healthcare Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (`cardio:org-london-health-sciences-centre-research-institute-or-lawson-92e6ca`)
- Registry lists this organization as a collaborator: Baxter Healthcare Corporation (`cardio:org-baxter-healthcare-corporation`)

## Provenance

Content hash: 496b38a7225eb440eeae2f4034eda0cfcdd7f2059b006c91c59c738152a75be0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
